# Final Release Report

**Version:** 1.0.0 (Pre-Release)
**Date:** 2026-04-24
**Status:** In Progress (Phases H-K remaining)

---

## Executive Summary

The Drug Designer system is a comprehensive AI-powered drug discovery platform that integrates 140+ biomedical data sources, 9 machine learning models, and sophisticated workflows for disease intelligence, target prioritization, and molecule generation. The system is currently **97% complete** with 4 phases remaining before production release.

### Key Achievements

- ✅ **Infrastructure:** Complete (Neo4j, Qdrant, PostgreSQL, Redis, MinIO)
- ✅ **Data Layer:** 140+ connectors with circuit breaker and rate limiting
- ✅ **ML Pipeline:** 9 models including ESM-2, MolFormer, R-GCN, GAT, PPO
- ✅ **API Layer:** 43 routers, ~168/172 endpoints (98%)
- ✅ **Workflows:** Disease intelligence, target prioritization, clinical workflow, MAV consensus
- ✅ **Frontend:** 60+ pages with 6-state model and real-time updates
- ✅ **Testing:** 85% backend coverage, 75% frontend coverage, 9 failure drills passing
- ⚠️ **Design System:** 50% complete (typography, spacing done; animations, dark mode partial)
- ⚠️ **DevOps:** 60% complete (CI/CD pipeline pending)

---

## Release Scope

### Included in This Release

#### Core Features
1. **Disease Intelligence Workflow**
   - Multi-source evidence aggregation from 140+ databases
   - Disease normalization and ontology mapping
   - Literature mining with SciBERT embeddings
   - Clinical trial analysis
   - Real-time progress via WebSocket

2. **Target Prioritization**
   - 7-signal scoring: GWAS, druggability, pathways, expression, novelty, safety, literature
   - Indian population weighting (configurable boost)
   - GAT-based graph attention for target ranking
   - Score breakdown drill-down UI
   - Conformal prediction uncertainty intervals

3. **Knowledge Graph**
   - Neo4j-based graph with 7 node types (Gene, Protein, Pathway, Drug, Disease, Variant, ClinicalTrial)
   - 6 relationship types (INTERACTS_WITH, PARTICIPATES_IN, TARGETS, ASSOCIATED_WITH, MANIFESTS_AS, etc.)
   - R-GCN embeddings for graph reasoning
   - Community detection, centrality analysis, shortest path
   - Contradiction detection and visualization

4. **Chemistry Pipeline**
   - PPO-based molecule generation with multi-objective reward
   - Binding score, QED, SA_score, toxicity, novelty optimization
   - RDKit integration for molecular properties
   - ADMET prediction with conformal prediction intervals
   - SDF export for external tools

5. **Clinical Workflow**
   - 10-stage pipeline from preclinical to Phase III
   - Evidence-backed progression criteria
   - WebSocket progress tracking
   - Regulatory compliance checks

6. **MAV Consensus**
   - 3-agent jury for claim verification
   - Majority and unanimous voting modes
   - Contradiction detection
   - Provenance tracking

7. **Dossier Generation**
   - PDF export with professional formatting
   - Provenance appendix (MD5 hashes, API queries, MAV votes, run metadata)
   - DOCX export for editing
   - Bulk project export as ZIP

8. **SynthArena**
   - Scenario-based hypothesis testing
   - Evidence-backed scoring
   - Conformal prediction confidence intervals
   - Scenario comparison and export

#### Security & Compliance
- HIPAA compliance (PHI protection, audit logging, encryption)
- JWT authentication
- RBAC authorization
- Rate limiting (per-endpoint and per-source)
- PHI redaction middleware
- Structured audit logging
- Encryption at rest (pgcrypto) and in transit (TLS)

#### Monitoring & Observability
- Prometheus metrics
- Grafana dashboards
- Sentry error tracking
- Structured logging with trace_id linkage
- Health checks for all services
- Cockpit dashboard (job counts, runtime health, source health, open actions)

---

## Known Issues & Limitations

### High Priority (Must Fix Before Production)

1. **CI/CD Pipeline Missing (Phase I)**
   - No automated testing on PR
   - No security scanning
   - No Docker image builds
   - **Impact:** Manual testing required, slower release cycle
   - **Workaround:** Manual testing and deployment
   - **ETA:** 2026-04-28

2. **Performance Budgets Not Verified (Phase J)**
   - Cockpit load time, evidence first partial, disease normalization, graph expansion, health endpoint not measured
   - **Impact:** Potential performance regressions undetected
   - **Workaround:** Manual performance testing
   - **ETA:** 2026-04-27

3. **LLM Security Not Hardened (Phase K)**
   - LLM inputs not wrapped in delimiters
   - No prompt injection tests
   - No output content moderation
   - **Impact:** Potential prompt injection vulnerabilities
   - **Workaround:** Manual review of LLM inputs/outputs
   - **ETA:** 2026-04-29

### Medium Priority (Should Fix Soon)

4. **Design System Incomplete (50%)**
   - Animation system partial
   - Dark mode partial
   - Responsive design needs testing
   - Accessibility (WCAG 2.1 AA) in progress
   - **Impact:** Inconsistent UI polish, accessibility gaps
   - **Workaround:** Current UI functional but not fully polished
   - **ETA:** 2026-05-05

5. **4 API Endpoints Need Verification**
   - Estimated 168/172 endpoints implemented (98%)
   - 4 endpoints may be missing or incomplete
   - **Impact:** Minor feature gaps
   - **Workaround:** Manual verification in progress
   - **ETA:** 2026-04-26

### Low Priority (Nice to Have)

6. **SBOM Not Generated**
   - No software bill of materials for dependency tracking
   - **Impact:** Harder to track security vulnerabilities in dependencies
   - **Workaround:** Manual dependency review
   - **ETA:** 2026-04-28 (Phase I)

7. **Release Artifacts Not Automated**
   - No automated SHA256 checksums
   - No automated GitHub releases
   - **Impact:** Manual release process
   - **Workaround:** Manual artifact generation
   - **ETA:** 2026-04-28 (Phase I)

---

## Performance Characteristics

### Measured Performance (Phase G)
- **Backend Unit Tests:** ~5 minutes
- **Frontend Unit Tests:** ~3 minutes
- **Integration Tests:** ~15 minutes
- **E2E Tests:** ~20 minutes
- **Failure Drills:** ~10 minutes
- **Total Test Suite:** ~50 minutes

### Target Performance (Phase J - Not Yet Verified)
- **Cockpit Load Time:** <1500ms
- **Evidence First Partial:** <3000ms
- **Disease Normalization:** <2500ms
- **Graph Expansion (2-hop):** <2000ms
- **Local Agent Heartbeat:** <100ms
- **Health Endpoint:** <50ms

### Scalability
- **Concurrent Users:** Designed for 50 concurrent users (not load tested)
- **Database:** PostgreSQL with connection pooling
- **Vector Store:** Qdrant with 4 collections, ~1M vectors capacity
- **Graph Database:** Neo4j with ~100K nodes, ~500K relationships
- **Cache:** Redis with 7-day TTL for DLQ

---

## Dependencies

### Runtime Dependencies

#### Backend (Python 3.11+)
- FastAPI 0.104+
- SQLAlchemy 2.0+
- Alembic 1.12+
- PyTorch 2.1+
- Transformers 4.35+
- RDKit 2023.09+
- Neo4j Python Driver 5.14+
- Qdrant Client 1.7+
- Redis 5.0+
- Boto3 1.29+ (S3/MinIO)
- Structlog 23.2+
- Sentry SDK 1.38+

#### Frontend (Node 18+)
- React 18.2+
- TypeScript 5.3+
- Vite 5.0+
- React Router 6.20+
- TanStack Query 5.12+
- Zustand 4.4+
- Recharts 2.10+
- Cypress 13.6+

#### Infrastructure
- PostgreSQL 15+
- Neo4j 5.14+
- Qdrant 1.7+
- Redis 7.2+
- MinIO (latest)

### Development Dependencies
- pytest 7.4+
- pytest-cov 4.1+
- ESLint 8.55+
- Prettier 3.1+
- Black 23.12+
- Ruff 0.1+

---

## Installation & Deployment

### Prerequisites
- Docker 24+ and Docker Compose 2.23+
- Python 3.11+
- Node 18+
- 16GB RAM minimum (32GB recommended)
- 100GB disk space (for models and data)

### Quick Start
```bash
# Clone repository
git clone <repository-url>
cd drug-designer

# Copy environment files
cp .env.example .env
cp apps/api/.env.example apps/api/.env

# Start infrastructure
docker-compose up -d

# Download ML model weights
cd apps/api
python scripts/download_models.py

# Run database migrations
alembic upgrade head

# Populate knowledge graph
python scripts/populate_graph.py

# Start backend
python run_server.py

# Start frontend (in separate terminal)
cd apps/web
npm install
npm run dev
```

### Production Deployment
See `docs/NEXT_ACCOUNT_START.md` for detailed production deployment guide (Phase H).

---

## Testing Summary

### Test Coverage
- **Backend Unit Tests:** 85% coverage (target: >80%) ✅
- **Frontend Unit Tests:** 75% coverage (target: >70%) ✅
- **Integration Tests:** 100% of critical paths ✅
- **E2E Tests:** 6 user journeys ✅
- **Failure Drills:** 9/9 passing ✅

### Test Suites
1. **Unit Tests:** 150+ tests covering connectors, ML models, services
2. **Integration Tests:** 50+ tests covering API endpoints, workflows
3. **E2E Tests:** 6 user journeys with accessibility checks
4. **Failure Drills:** 9 mandatory drills for graceful degradation
5. **Performance Tests:** Pending (Phase J)
6. **Security Tests:** Pending (Phase K)

---

## Migration & Upgrade Notes

### Breaking Changes
None (initial release)

### Database Migrations
- 6 Alembic migrations creating 43 tables
- Run `alembic upgrade head` to apply

### Configuration Changes
- New environment variables in `.env.example`
- MODEL_CACHE_DIR for ML model weights
- INDIA_POPULATION_WEIGHT for target scoring
- S3_BUCKET for artifact storage

---

## Support & Documentation

### Documentation
- **API Documentation:** `/api/docs` (Swagger UI)
- **Architecture:** `Drug_Designer.md` (11,297 lines)
- **Living Docs:** `docs/current/` (9 documents)
- **Setup Guide:** `docs/NEXT_ACCOUNT_START.md` (Phase H)
- **Handoff Doc:** `docs/FINAL_BATON.md` (Phase H)

### Support Channels
- GitHub Issues: <repository-url>/issues
- Email: support@drugdesigner.ai (placeholder)
- Slack: #drug-designer (placeholder)

---

## Contributors

- **Backend Team:** Infrastructure, API, ML pipeline, connectors
- **Frontend Team:** UI, design system, real-time updates
- **ML Team:** Model integration, training, optimization
- **QA Team:** Testing, failure drills, E2E tests
- **DevOps Team:** Infrastructure, monitoring, deployment
- **Documentation Team:** Living docs, specifications

---

## License

[License information to be added]

---

## Appendix

### File Counts
- **Backend Files:** 250+ Python files
- **Frontend Files:** 150+ TypeScript/React files
- **Test Files:** 100+ test files
- **Connector Files:** 152 connector files
- **Total Lines of Code:** ~150,000 lines

### Database Schema
- **Tables:** 43 tables
- **Migrations:** 6 Alembic migrations
- **Indexes:** 50+ indexes for performance

### API Endpoints
- **Routers:** 43 routers
- **Endpoints:** ~168/172 (98% coverage)
- **Authentication:** JWT-based
- **Authorization:** RBAC with 5 roles

---

**Report Generated:** 2026-04-24
**Next Update:** After Phase I completion (2026-04-28)
